Literature DB >> 33334944

Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study.

Tài Pham1,2,3,4, Antonio Pesenti5,6, Giacomo Bellani7,8, Gordon Rubenfeld9, Eddy Fan10,11, Guillermo Bugedo12, José Angel Lorente13,14,15, Antero do Vale Fernandes16, Frank Van Haren17,18,19, Alejandro Bruhn12, Fernando Rios20, Andres Esteban21, Luciano Gattinoni22, Anders Larsson23, Daniel F McAuley24,25, Marco Ranieri26, B Taylor Thompson27, Hermann Wrigge28,29, Laurent J Brochard30,2,31, John G Laffey1,2,32,33,31.   

Abstract

BACKGROUND: Current incidence and outcome of patients with acute hypoxaemic respiratory failure requiring mechanical ventilation in the intensive care unit (ICU) are unknown, especially for patients not meeting criteria for acute respiratory distress syndrome (ARDS).
METHODS: An international, multicentre, prospective cohort study of patients presenting with hypoxaemia early in the course of mechanical ventilation, conducted during four consecutive weeks in the winter of 2014 in 459 ICUs from 50 countries (LUNG SAFE). Patients were enrolled with arterial oxygen tension/inspiratory oxygen fraction ratio ≤300 mmHg, new pulmonary infiltrates and need for mechanical ventilation with a positive end-expiratory pressure of ≥5 cmH2O. ICU prevalence, causes of hypoxaemia, hospital survival and factors associated with hospital mortality were measured. Patients with unilateral versus bilateral opacities were compared.
FINDINGS: 12 906 critically ill patients received mechanical ventilation and 34.9% with hypoxaemia and new infiltrates were enrolled, separated into ARDS (69.0%), unilateral infiltrate (22.7%) and congestive heart failure (CHF; 8.2%). The global hospital mortality was 38.6%. CHF patients had a mortality comparable to ARDS (44.1% versus 40.4%). Patients with unilateral-infiltrate had lower unadjusted mortality, but similar adjusted mortality compared to those with ARDS. The number of quadrants on chest imaging was associated with an increased risk of death. There was no difference in mortality comparing patients with unilateral-infiltrate and ARDS with only two quadrants involved.
INTERPRETATION: More than one-third of patients receiving mechanical ventilation have hypoxaemia and new infiltrates with a hospital mortality of 38.6%. Survival is dependent on the degree of pulmonary involvement whether or not ARDS criteria are reached.
Copyright ©ERS 2021.

Entities:  

Mesh:

Year:  2021        PMID: 33334944     DOI: 10.1183/13993003.03317-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Identification of persistent and resolving subphenotypes of acute hypoxemic respiratory failure in two independent cohorts.

Authors:  Neha A Sathe; Leila R Zelnick; Carmen Mikacenic; Eric D Morrell; Pavan K Bhatraju; J Brennan McNeil; Susanna Kosamo; Catherine L Hough; W Conrad Liles; Lorraine B Ware; Mark M Wurfel
Journal:  Crit Care       Date:  2021-09-15       Impact factor: 19.334

2.  Assessment of different computing methods of inspiratory transpulmonary pressure in patients with multiple mechanical problems.

Authors:  Kamil İnci; Nazlıhan Boyacı; İskender Kara; Gül Gürsel
Journal:  J Clin Monit Comput       Date:  2021-09-03       Impact factor: 1.977

3.  Non-invasive ventilation for acute hypoxaemic respiratory failure: a propensity-matched cohort study.

Authors:  Dilip Jayasimhan; Robert Adam Martynoga; Sarah M Fairweather; Catherina L Chang
Journal:  BMJ Open Respir Res       Date:  2022-05

Review 4.  The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?

Authors:  Michael A Matthay; B Taylor Thompson; Lorraine B Ware
Journal:  Lancet Respir Med       Date:  2021-04-26       Impact factor: 30.700

5.  The PANDORA Study: Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in the Pre-COVID-19 Era.

Authors:  Jesús Villar; Juan M Mora-Ordoñez; Juan A Soler; Fernando Mosteiro; Anxela Vidal; Alfonso Ambrós; Lorena Fernández; Isabel Murcia; Belén Civantos; Miguel A Romera; Adrián Mira; Francisco J Díaz-Domínguez; Dácil Parrilla; J Francisco Martínez-Carmona; Domingo Martínez; Lidia Pita-García; Denis Robaglia; Ana Bueno-González; Jesús Sánchez-Ballesteros; Ángel E Pereyra; Mónica Hernández; Carlos Chamorro-Jambrina; Pilar Cobeta; Raúl I González-Luengo; Raquel Montiel; Leonor Nogales; M Mar Fernández; Blanca Arocas; Álvaro Valverde-Montoro; Ana M Del Saz-Ortiz; Victoria Olea-Jiménez; José M Añón; Pedro Rodríguez-Suárez; Rosa L Fernández; Cristina Fernández; Tamas Szakmany; Jesús M González-Martín; Carlos Ferrando; Robert M Kacmarek; Arthur S Slutsky
Journal:  Crit Care Explor       Date:  2022-04-29

Review 6.  Early Identification and Diagnostic Approach in Acute Respiratory Distress Syndrome (ARDS).

Authors:  François Arrivé; Rémi Coudroy; Arnaud W Thille
Journal:  Diagnostics (Basel)       Date:  2021-12-08

7.  What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?

Authors:  Samuel M Brown; Ithan D Peltan; Christina Barkauskas; Angela J Rogers; Virginia Kan; Annetine Gelijns; B Taylor Thompson
Journal:  Ann Am Thorac Soc       Date:  2021-12

Review 8.  Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.

Authors:  Domenico Luca Grieco; Salvatore Maurizio Maggiore; Oriol Roca; Elena Spinelli; Bhakti K Patel; Arnaud W Thille; Carmen Sílvia V Barbas; Marina Garcia de Acilu; Salvatore Lucio Cutuli; Filippo Bongiovanni; Marcelo Amato; Jean-Pierre Frat; Tommaso Mauri; John P Kress; Jordi Mancebo; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2021-07-07       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.